Intersect ENT Reports First Quarter 2017 Results
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2017.
First Quarter Financial Highlights
• First quarter 2017 revenue was $20.5 million, a 23% increase over the first quarter 2016.
• First quarter 2017 gross margin was 86% compared to 81% in the first quarter 2016.
First Quarter Financial Highlights
• First quarter 2017 revenue was $20.5 million, a 23% increase over the first quarter 2016.
• First quarter 2017 gross margin was 86% compared to 81% in the first quarter 2016.